

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 21, 2026 accepted 4:30 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Oct 9, 2026 accepted 4:30 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Apr 15, 2026 accepted 4:32 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 8, 2026 accepted 8:30 AM ET | TCRTAlaunos Therapeutics, Inc. | 1.02Agreement terminated3.03Holder rights modified8.01Other events | DocumentSEC ↗ |
Jul 2, 2025 accepted 5:30 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice5.02Officer / director change | DocumentSEC ↗ |
Apr 14, 2025 accepted 9:15 AM ET | TCRTAlaunos Therapeutics, Inc. | 1.01Material agreement1.02Agreement terminated3.02Unregistered equity sale3.03Holder rights modified5.03Bylaws / fiscal year | DocumentSEC ↗ |
Apr 11, 2025 accepted 4:45 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |
Oct 10, 2024 accepted 8:30 AM ET | TCRTAlaunos Therapeutics, Inc. | 1.02Agreement terminated2.02Earnings release | DocumentSEC ↗ |
Jun 21, 2024 accepted 5:01 PM ET | TCRTAlaunos Therapeutics, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Nov 14, 2023 accepted 7:40 AM ET | TCRTAlaunos Therapeutics, Inc. | 2.02Earnings release3.01Delisting notice | DocumentSEC ↗ |
Jul 5, 2023 accepted 4:15 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 4, 2023 accepted 4:52 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 18, 2022 accepted 5:01 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 27, 2021 accepted 4:05 PM ET | TCRTAlaunos Therapeutics, Inc. | 2.05Restructuring costs7.01Reg FD disclosure | DocumentSEC ↗ |
May 6, 2021 accepted 4:17 PM ET | TCRTAlaunos Therapeutics, Inc. | 2.02Earnings release2.05Restructuring costs | DocumentSEC ↗ |
Dec 30, 2020 accepted 5:00 PM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Dec 18, 2020 accepted 8:31 AM ET | TCRTAlaunos Therapeutics, Inc. | 3.01Delisting notice5.02Officer / director change5.03Bylaws / fiscal year5.07Shareholder vote8.01Other events | DocumentSEC ↗ |
Oct 11, 2018 accepted 9:05 AM ET | TCRTAlaunos Therapeutics, Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Apr 5, 2013 accepted 9:11 PM ET | TCRTAlaunos Therapeutics, Inc. | 2.02Earnings release2.05Restructuring costs5.02Officer / director change | DocumentSEC ↗ |
Jul 30, 2010 accepted 1:12 PM ET | TCRTAlaunos Therapeutics, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Sep 19, 2005 accepted 5:17 PM ET | TCRTAlaunos Therapeutics, Inc. | 2.01Acquisition / disposition3.02Unregistered equity sale5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |